Sands Capital Management 13F holdings, Q3 2008
Holdings as of September 30, 2008 · filings on SEC EDGAR · latest filing →
Sands Capital Management disclosed 36 US equity positions worth $9.3bn in its Q3 2008 13F filing. The largest position was GENZYME CORP at 9.3% of the reported book, followed by NATIONAL OILWELL VARCO INC and SLB. Against the Q2 2008 filing, it opened 1 new position, added to 6 and reduced 28 among the top 36 holdings.
What did Sands Capital Management own in Q3 2008? Top 36 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2008 |
|---|---|---|---|---|---|---|---|
| 1 | GENZYME CORP | 9.3% | $865.6m | 10,700,879 | -9% | reduced | |
| 2 | NATIONAL OILWELL VARCO INC | 8.5% | $796.0m | 15,847,398 | -3% | reduced | |
| 3 | SLB SCHLUMBERGER LTD | Energy | 8.1% | $755.6m | 9,675,414 | -9% | reduced |
| 4 | ALLERGAN INC | 8.0% | $745.4m | 14,473,614 | -9% | reduced | |
| 5 | AAPL APPLE INC | Technology | 7.5% | $696.6m | 6,128,497 | -3% | reduced |
| 6 | V VISA INC | Financial Services | 5.7% | $528.1m | 8,602,577 | -8% | reduced |
| 7 | INTERCONTINENTALEXCHANGE INC | 5.5% | $510.4m | 6,326,069 | 29% | added | |
| 8 | E M C CORP MASS | 5.2% | $485.5m | 40,597,351 | -8% | reduced | |
| 9 | CME CME GROUP INC | Financial Services | 4.8% | $443.8m | 1,194,464 | -9% | reduced |
| 10 | CRM SALESFORCE | Technology | 4.5% | $420.5m | 8,687,330 | -9% | reduced |
| 11 | MCO MOODYS CORP | Financial Services | 4.5% | $418.6m | 12,311,608 | -9% | reduced |
| 12 | AMERICA MOVIL SAB DE CV SPON | 4.5% | $418.4m | 9,025,379 | -30% | reduced | |
| 13 | FMC TECHNOLOGIES INC | 4.0% | $376.6m | 8,089,954 | 30% | added | |
| 14 | AVGO BROADCOM CORP | Technology | 4.0% | $373.3m | 20,038,412 | -26% | reduced |
| 15 | SYK STRYKER CORP | Healthcare | 3.8% | $358.4m | 5,752,621 | -9% | reduced |
| 16 | LVS LAS VEGAS SANDS CORP | Consumer Cyclical | 3.7% | $344.7m | 9,545,423 | -8% | reduced |
| 17 | EXPD EXPEDITORS INTL WASH INC | Industrials | 2.8% | $264.4m | 7,588,599 | -9% | reduced |
| 18 | CERNER CORP | 1.9% | $179.9m | 4,029,747 | -16% | reduced | |
| 19 | IRON MTN INC | 1.8% | $163.6m | 6,702,706 | -9% | reduced | |
| 20 | ABRAXIS BIOSCIENCE INC NEW | 0.9% | $86.8m | 1,258,841 | -10% | reduced | |
| 21 | MINDRAY MEDICAL INTL LTD SPON | 0.5% | $47.8m | 1,416,860 | 497% | added | |
| 22 | NUVASIVE INC | 0.2% | $14.6m | 295,700 | -10% | reduced | |
| 23 | CELG CELGENE CORP | 0.1% | $6.1m | 96,620 | 18% | added | |
| 24 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 0.1% | $5.8m | 220,700 | 56% | added |
| 25 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 0.1% | $5.4m | 162,500 | -3% | reduced |
| 26 | SEQUENOM INC | 0.1% | $4.8m | 179,700 | -2% | reduced | |
| 27 | HANSEN MEDICAL INC | 0.0% | $4.7m | 346,000 | 31% | added | |
| 28 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.0% | $4.1m | 143,200 | -3% | reduced |
| 29 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 0.0% | $2.6m | 238,100 | -2% | reduced |
| 30 | GTX INC DEL | 0.0% | $2.4m | 128,100 | -26% | reduced | |
| 31 | SAVIENT PHARMACEUTICALS INC | 0.0% | $2.4m | 161,100 | – | new | |
| 32 | CSCO CISCO SYS INC | Technology | 0.0% | $2.4m | 105,850 | -2% | reduced |
| 33 | MEDAREX INC | 0.0% | $1.5m | 225,650 | -3% | reduced | |
| 34 | ISHARES TR RUSSELL1000GRW | 0.0% | $1.3m | 27,497 | -70% | reduced | |
| 35 | TROW PRICE T ROWE GROUP INC | Financial Services | 0.0% | $376.0k | 7,000 | 0% | held |
| 36 | WALGREEN CO | 0.0% | $232.0k | 7,500 | -24% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.